INTRODUCTION
Inflammation plays a pivotal role in the genesis of hypertension and its complications (Li et al., 2007) . Peripheral blood monocytes (PBMCs) were preactivated in patients with essential hypertension (EH) and produced inflammatory mediator like interleukin-1 beta (IL-1β) (Dorffel et al., 1999) . IL-1β is one of the main regulators of the immune and inflammatory response with a lot of proinflammatory properties (Andrzejczak et al., 2007) . It was shown that individuals with essential hypertension had increased IL-beta secretion in human peripheral blood mononuclear cells (PBMCs) after been stimulated by angiotensin II (Ang II) (Zhao et al., 2004) . Ang II, the key effector of the rennin-angiotensin system, is also capable of inducing inflammatory response in the vascular wall. Ang II enhances the production of reactive *Corresponding author. E-mail: farkhondehnemati@gmail.com. Tel: 0098 911 3140559. Fax. 0098 123 2253326. oxygen species through stimulation of NAD(P)H oxidase. Increased oxidative stress act as signal transduction messengers for several important transcription factors including nuclear factor-kappaB (NF-kappaB), which is a pivotal transcription factor in chronic inflammatory diseases. NF-kappaB regulates the transcription of genes for pro-inflammatory cytokines, adhesion molecules and chemokines (Cheng et al., 2005) .
It has been previously shown that some drugs used in cardiovascular diseases, such as valsartan (Li et al., 2005) and simvastatin (Zhao et al., 2004) , could reduce IL-1β secretion in PBMCs of patients with essential hypertension. Thiazides are also used to treat hypertension. In this study, we investigated the effect of hydrochlorothiazide (HCT) on the secretion of IL-1β by PBMCs in healthy subject. morning. None of the participants had diabetes mellitus, macroproteinuria, creatinemia, hypothyroidism, abnormal liver and muscle enzymes, acute and/or chronic infections, autoimmune or neoplastic diseases. None had a history of cardiovascular disease or were taking medication or other agents known to affect inflammatory response. None of them were smokers. Informed consent was obtained from all participants. The protocol was approved by the local ethical committee.
MATERIALS AND METHODS

Blood
Isolation of peripheral blood mononuclear cells
Peripheral blood was immediately drawn into sterile 15 ml containing sodium heparin, layered onto an equal volume of Ficoll and centrifuged at 1500 × g for 20 min. Cells were then harvested from the Ficoll-plasma interface and washed three times in RPMI1640 medium (Gibco-BRL) containing 2 mmol/L glutamine (Sigma), 10% heat-inactivated fetal calf serum (Gibco-BRL), 100 U/ml penicillin and 100 µg/ml streptomycin. Cells were suspended at 1 × 10 6 /ml in RPMI1640 supplemented as above. Cell viability was always >95%, as estimated by trypan blue exclusion. The cell suspension was plated at 1 ml per well in 24-well flat-bottomed tissue culture plates. Then, they were incubated with or without a physiologically relevant concentration of Ang II (10 -10 ml/l) at 37°C in 95% humidified air and 5% CO2. In additional experiments, cells were preincubated with hydrochlorothiazide (HCT, 10 -7 , 10 -8 , 10
-9 mol/L). After 24 h, cell supernatants were harvested and stored at -70°C for cytokine analysis (Li et al., 2005) .
Statistical analysis
Results were presented as mean ± SEM. Differences between control and test values were determined by Student's t test and were accepted as significant when p<0.05. Figure 1 demonstrates the effect of HCT (H1 = 10 -9
RESULTS AND DISCUSSION
, H2 = 10 -8 , H3 = 10 -7 mol/L) on the secretion of IL-1β (pg/ml) by PBMCs after stimulation by Ang II (10 -10 mol/L). The results show that HCT, at concentration of 10 -9 mol/L, significantly increased IL-1β secretion when compared with the control group. Although another concentration (10 -8 mol/L) also increased IL-1β secretion, the difference was not significant when compared with the control group.
In this study, we investigated the effects of HCT on IL-1β secretion by PBMCs obtained from healthy subjects. The results show that HCT at concentration of 10 -9 mol/L significantly increased IL-1β secretion stimulated by Ang II (10 -10 mol/L) to 43%. Although the level of increment was about 17% for the concentration of 10 -8 mol/L, the difference was not statistically significant when compared with the control. The concentration, 10 -7 mol/L of HCT not only did not increase IL-1β secretion but also a rather non-significant decrease was observed. The latter concentration was not clinically relevant because the peak achievable concentration of HCT was about 10 -8 mol/L (Brunton et al., 2006) .
Prior reports have emphasized the importance of inflammation in hypertension. The data raises a possible role of anti-inflammatory therapy as an experimental means to reduce risk in patients with hypertension. On the contrary, any agent capable of stimulating inflammatory responses might worsen the condition. The findings of this preliminary study indicate that clinically relevant concentrations of HCT could increase IL-1β secretion by PBMCs. Future studies may clarify administration in patients with essential hypertension. HCT might result in aggravation of inflammatory processes in vascular wall and worsen the condition in long term.
